Search

Han Xu

from Agoura Hills, CA
Age ~55
Get Report
Also known as:
Xu Han
Related to:
Shimin Xu, 54Peter Jian Zhou, 57Wangling Ling Hu, 71Linda XuHarry Xu, 77Dualex Xu, 55
Connected to:
Angmai Xu, 69Baoji Xu, 61Baopei Xu, 86Beibei Xu, 41Bingxin Xu, 37Chan Xu, 62Chao Xu, 66Chengkun B Xu, 61Chenxi Xu, 32Chunchun Xu, 35

Han Xu Phones & Addresses

  • Agoura Hills, CA
  • 1052 Larry Ct, Newbury Park, CA 91320
  • Moorpark, CA

Professional Records

Medicine Doctors

Han Xu Photo 1

Han Xu

View page
Specialties:
Medical Genetics
Medical Oncology
Public Health & General Preventive Medicine

Resumes

Resumes

Han Xu Photo 2

Student At University Of Southern California

View page
Location:
Greater Los Angeles Area
Industry:
Motion Pictures and Film
Han Xu Photo 3

Tax Analyst At Hp China

View page
Position:
Tax specialist at HP company----- China Hewlett-Packard limited
Location:
Beijing City, China
Industry:
Computer Hardware
Work:
HP company----- China Hewlett-Packard limited since Oct 2007
Tax specialist
Kraft foods International-China company Jan 2004 - Sep 2007
AP Accountant & Tax accountant
Education:
Dept. of Accounting, Capital University of Business & Economy
B.E, Finance Management
Han Xu Photo 4

Han Xu

View page
Education:
Department of Sociology, Lse 1999 - 2000
Master of Science, Masters, Industrial Relations
Languages:
English
Han Xu Photo 5

Senior Director

View page
Location:
Newbury Park, CA
Industry:
Biotechnology
Work:
A2 Biotherapeutics, Inc
Senior Director
A2 Biotherapeutics, Inc Feb 2018 - Dec 2018
Director
Amgen Mar 2005 - Jan 2018
Principal Scientist
Amgen Sep 2002 - Mar 2005
Scientist
Education:
Rice University Jun 1998
Rice University May 1997
Rice University 1997
Masters, Master of Arts Rice University 1993 - 1997
Nankai University Jul 1991
Nankai University 1991
Bachelors, Bachelor of Science Nankai University 1987 - 1991
Skills:
Drug Discovery
Biotechnology
High Throughput Screening
Molecular Biology
Protein Chemistry
Assay Development
Cell
Cell Culture
Life Sciences
Drug Development
Laboratory Automation
Biopharmaceuticals
Biochemistry
Technology Transfer
Signal Transduction
Lifesciences
Drug Design
Tissue Culture
Cell Biology
Fluorescence
Gpcrs
Chromatography
Pharmacology
Protein Purification
Elisa
Western Blotting
Cancer
Protein Expression
Transfection
Flow Cytometry
Pcr
Sds Page
Immunoassays
Antibodies
In Vitro
Proteomics
Dna
Pharmaceutical Industry
Han Xu Photo 6

Professional

View page
Location:
United States
Han Xu Photo 7

Han Xu

View page
Location:
United States
Han Xu Photo 8

Han Xu La Caada Flintridge, CA

View page
Work:
Shanghai Jiao Tong University

Sep 2007 to Jun 2011
Manager
Shanghai Jiao Tong University

Jun 2009 to Aug 2009
Internship
Education:
University of Southern California
Sep 2011 to May 2013
MS in Material Engineering
University of Southern California
Sep 2012 to Dec 2012
Research
Shanghai Jiao Tong University
Dec 2010 to Jul 2011
Research
Shanghai Jiao Tong University
Sep 2007 to Jul 2011
BS in Material Science and Engineering
Shanghai Jiao Tong University
Jan 2010 to Dec 2010
Research Assistant
Shanghai Jiao Tong University
Jun 2009 to Dec 2009
Research

Publications

Wikipedia References

Han Xu Photo 9

Han Xu (Basketball)

Han Xu Photo 10

Han Xu (Footballer, Born 1988)

Us Patents

Compositions And Methods For Treating Her2 Positive Cancers

View page
US Patent:
20220339194, Oct 27, 2022
Filed:
Jun 28, 2022
Appl. No.:
17/809409
Inventors:
- Agoura Hills CA, US
Agnes Hamburger - Agoura Hills CA, US
Jee Young Mock - Agoura Hills CA, US
Julyun OH - Agoura Hills CA, US
Han Xu - Agoura Hills CA, US
Carl Alexander Kamb - Agoura Hills CA, US
International Classification:
A61K 35/17
C07K 14/725
C07K 16/28
C07K 16/30
Abstract:
The disclosure relates to immune cells comprising a dual receptor system responsive to loss of heterozygosity in a target cell, and methods of making and using same. The first receptor comprises activator receptor specific to a HER2 antigen, and the second receptor comprises an inhibitory receptor specific to an antigen lost in cancer but not wild type cells, that inhibits activation of the immune cells by the first receptor.

Compositions And Methods For Treating Egfr Positive Cancers

View page
US Patent:
20220273721, Sep 1, 2022
Filed:
May 17, 2022
Appl. No.:
17/663758
Inventors:
- Agoura Hills CA, US
Han XU - Agoura Hills CA, US
Carl Alexander KAMB - Agoura Hills CA, US
International Classification:
A61K 35/17
A61K 35/15
C07K 14/705
C07K 16/28
C12N 5/09
A61P 35/00
Abstract:
The disclosure provides immune cells comprising a first activator receptor and a second inhibitory receptor, and methods of making and using same for the treatment of cancer.
Control profile
Han Xu from Agoura Hills, CA, age ~55 Get Report